INTRODUCTION
The association of various chronic infections and development of a malignant state is an established fact. [1] [2] [3] Various mechanisms have been postulated to explain this association. In case of the gall bladder, a chronic typhoid carrier state is established to be a high risk factor for development of carcinoma of the gall bladder especially in patients harboring gall stones. 1, 2 The pathophysiologic mechanism underlying this association in reviewed.
Pathophysiology
Carcinoma of the gall bladder is the fifth most common gastrointestinal tract cancer and has established endemicity in certain countries. 4 In India, northern states can almost be described as endemic areas for carcinoma of gall bladder. This carcinoma has been co-related with various predisposing factors. Genetic disorders such as multiple familial polyposis (Gardner`s syndrome), Peutz-Jegher`s syndrome, porcelain gall bladder and anomalous pancreatico-biliary ductal communication as seen in choledochal cyst. Long standing gall stones also predispose to the development of gall bladder cancer. 3, 4 There is complex interplay of genetic predisposition, chronic infection and various lifestyle factors which are still poorly understood. However, a variety of mechanisms for carcinogenesis in chronic typhoid carriers has been postulated.
Mechanism of carcinogenesis
Though bile has a strong detergent action which is toxic to bacteria yet Salmonella typhi has the unique property of being resistant to the detergent action of bile. This protection is offered by the presence of special genes in S. typhi namely the PhoP-PhoQ virulence factor. Gall bladder can get infected in many ways. Routes of infection to the gall bladder could either be ascending or descending in nature. [5] [6] [7] The ascending route through the sphincter of oddi is usually seen in patients who have undergone surgical intervention.eg biliary enteric anastomosis.
The descending route or haematogenous route whereby infection thrives in the liver and is then transmitted in secreted bile. Bacteria present in the biliary tract can lead to a variety of sequelae. However chronic bactero-bilia predisposes to gall stone formation. 8 The culture of organisms in such patients is variable and mixed in nature. In the context of S. typhi, the chronic carrier state is attained in those patients who have gall stones especially cholesterol stones. 8, 9 This is by way of biofilm formation. The O antigen capsule is essential for specific binding affinity between the S. typhi organism and cholesterol crystals. The O antigen capsule is the main component of the exopolysaccharide matrix which provides rigid strength to the biofilm thus protecting the bacteria within it. The operon which creates this capsule yihVW contains the ythP gene which codes for the symporter enzyme implicated in O antigen production. This operon is further upregulated when S. typhi is grown in an extremely bile rich culture. Thus the O antigen capsule production is a result of both biofilm production as well as bile induction. 10 Once a carrier state is established it leads to chronic inflammation of the gall bladder. The bacteria metabolize primary bile acids leading to production of potentially toxic carcinogens. Bacterial glucoronidase is one such toxic metabolite which has capability to produce mutagenic intermediates. Secondary bile acids in the gall bladder along with these compounds induce carcinogenic changes in the gall bladder epithelium.
The mechanism by which S. typhi induces carcinogenic changes is complex for which various mechanisms have been postulated. Bacterial glucuronidase which yields high energy intermediates, those are carcinogenic bacterial enzymes, may act on primary bile acid converting them to secondary bile acids. These secondary bile acids may attain high concentration there by inducing malignant transformation. 4, 5 High concentration of nitroso compounds produced by action of bacterial enzymes on nitrates also induces carcinogenic changes.
Effectively chronic persistent bacterial infection leads to an interrelated chain of events related to obstruction and persistent mechanical and chemical injury. 8 Mechanism by which S. typhi causes damage to epithelium of gall bladder has been extensively studied. 9, 10 Cytolethal distending toxin (CDT) is one of the first toxins to be associated with carcinogenicity by S. typhi. This toxin is a tripartite complex.
The CdtB subunit is the structural and functional component which is most active and is homologous to mammalian DNA se 1. The other components CdtA and CdtC mediate the binding of toxin to the plasma membrane of target cells.
Haghjoo et-al found that S. typhi produced a unique type of CdtB which requires bacterial internalization into the host cells. 11 This was observed in cell culture study using cos2 and Henle 407 cell lines. When cos2 cells were transfected with S. typhi the effect of CdtB subunit were fragmentations of chromatin. [11] [12] [13] The authors therefore concluded that S. typhi subsequent to internalization deviated from the usual endocytic pathway that leads to lysosomes reaching an unusual closed membrane bound component which not only could survive but also replicate abundantly to produce ant phagocytic Vi capsules. [14] [15] [16] Therefore Cdt plays a pivotal role in the carcinogenic potential of S. typhi.
S. typhi is human restricted pathogen known to cause chronic infections. CDT facilitates the persistence of infection by virtue of its immunomodulatory activity. [17] [18] [19] Once the CdtB reaches the cytosol, it enters the nucleus of the target cell and induces damage to the DNA. This is the most acceptable explanation for carcinogenicity of S. typhi. 12, 14 Mutation in multiple tumour suppressor genes and oncogenes (P53 and K-ras) may also add to the carcinogenic process. 
Clinical implication
Bile culture in patients with gall stones who suffer from S. typhi may be of help in establishing the chronic carrier state. 20, 21 PCR assay is mandatory in improving the diagnostic outcome of such culture studies. [22] [23] [24] PCR assay which specifically amplifies H1d flagellin gene sequence is used for the assay as this is homologous to S. typhi. [25] [26] [27] Detection of S. typhi antibody levels is also an important test to determine a chronic carrier state. [28] [29] [30] A chronic carrier state in patient with gall stone disease significantly increases the chance of developing a carcinoma of the gall bladder. So in patients with gall stones who give history of typhoid fever it would be good practice to carry antibody testing and PCR assay to detect the chronic carrier state. These patients should undergo cholecystectomy. 29, 30 CONCLUSION S. typhi infection is commonly seen in the Indian subcontinent.
History of S. typhi infection in patient with gall bladder stones should warrant further investigation to determine a chronic carrier state.
Chronic carrier of S. typhi should undergo prophylactic cholecystectomy to avoid developing the lethal disease of carcinoma of gall bladder.
